NCT02746068View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

PHASE3UnknownINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Osteoarthritis, Knee
Interventions
DRUG

AXS-02

DRUG

Placebo

Trial Locations (61)

2292

Broadmeadow

3004

Melbourne

3168

Clayton

4567

Noosa

5011

Adelaide

6009

Nedlands

7000

Hobart

10530

Hartsdale

14618

Rochester

16635

Duncansville

20902

Wheaton

23606

Newport News

27612

Raleigh

28204

Charlotte

29464

Mt. Pleasant

30114

Canton

32129

Accord Clinical Research, Port Orange

32806

Orlando

33012

Hialeah

33319

Lauderdale Lakes

33458

Jupiter

33472

Boynton Beach

33756

Clearwater

34232

Sarasota

34711

Clermont

34952

Port Saint Lucie

35216

Achieve Clinical Research, Birmingham

Birmingham

37067

Franklin

45227

Cincinnati

60453

Affinity Clinical Research Institute, Oak Lawn

Oak Lawn

60611

Chicago

63042

St Louis

64114

Kansas City

67114

Newton

71913

Hot Springs

75115

DeSoto

76309

Wichita Falls

77521

Baytown

78745

Austin

80230

Denver

85023

Phoenix

85224

Chandler

87106

Albuquerque

90036

Los Angeles

90806

Long Beach

91303

Canoga Park

91360

Thousand Oaks

91606

North Hollywood

91786

Upland

91941

La Mesa

92020

El Cajon

92103

San Diego

92805

Anaheim

95821

Sacramento

98007

Bellevue

06460

Milford

02111

Boston

02760

North Attleboro

02169

Quincy

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY

NCT02746068 - A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions | Biotech Hunter | Biotech Hunter